BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28539479)

  • 1. γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct.
    Ran Y; Hossain F; Pannuti A; Lessard CB; Ladd GZ; Jung JI; Minter LM; Osborne BA; Miele L; Golde TE
    EMBO Mol Med; 2017 Jul; 9(7):950-966. PubMed ID: 28539479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical role of γ-secretase and its inhibitors in cancer and cancer therapeutics.
    Song C; Zhang J; Xu C; Gao M; Li N; Geng Q
    Int J Biol Sci; 2023; 19(16):5089-5103. PubMed ID: 37928268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates.
    McKee TD; Loureiro RM; Dumin JA; Zarayskiy V; Tate B
    J Neurosci Methods; 2013 Feb; 213(1):14-21. PubMed ID: 23219895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment.
    López-Nieva P; González-Sánchez L; Cobos-Fernández MÁ; Córdoba R; Santos J; Fernández-Piqueras J
    Oncologist; 2021 Feb; 26(2):e298-e305. PubMed ID: 33191568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy.
    Ghanbari-Movahed M; Ghanbari-Movahed Z; Momtaz S; Kilpatrick KL; Farzaei MH; Bishayee A
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33673088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Inhibition of Signal Peptide Peptidase Family Members by Established γ-Secretase Inhibitors.
    Ran Y; Ladd GZ; Ceballos-Diaz C; Jung JI; Greenbaum D; Felsenstein KM; Golde TE
    PLoS One; 2015; 10(6):e0128619. PubMed ID: 26046535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Notch signaling pathway using γ-secretase inhibitor delivered by a low dose of Triton-X100 in cultured oral cancer cells.
    Nasrin A; Hassan M; Ye P
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2118-2124. PubMed ID: 29253571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance.
    McCaw TR; Inga E; Chen H; Jaskula-Sztul R; Dudeja V; Bibb JA; Ren B; Rose JB
    Oncologist; 2021 Apr; 26(4):e608-e621. PubMed ID: 33284507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition.
    Han J; Ma I; Hendzel MJ; Allalunis-Turner J
    Breast Cancer Res; 2009; 11(4):R57. PubMed ID: 19660128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes.
    Lee J; Song L; Terracina G; Bara T; Josien H; Asberom T; Sasikumar TK; Burnett DA; Clader J; Parker EM; Zhang L
    Biochemistry; 2011 Jun; 50(22):4973-80. PubMed ID: 21528914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signaling.
    Das A; Narayanam MK; Paul S; Mukhnerjee P; Ghosh S; Dastidar DG; Chakrabarty S; Ganguli A; Basu B; Pal M; Chatterji U; Banerjee SK; Karmakar P; Kumar D; Chakrabarti G
    J Biol Chem; 2019 Apr; 294(17):6733-6750. PubMed ID: 30824542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia.
    Tammam J; Ware C; Efferson C; O'Neil J; Rao S; Qu X; Gorenstein J; Angagaw M; Kim H; Kenific C; Kunii K; Leach KJ; Nikov G; Zhao J; Dai X; Hardwick J; Scott M; Winter C; Bristow L; Elbi C; Reilly JF; Look T; Draetta G; Van der Ploeg L; Kohl NE; Strack PR; Majumder PK
    Br J Pharmacol; 2009 Nov; 158(5):1183-95. PubMed ID: 19775282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Γ-secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment.
    Li T; Huang Y; Jin S; Ye L; Rong N; Yang X; Ding Y; Cheng Z; Zhang J; Wan Z; Harrison DC; Hussain I; Hall A; Lee DH; Lau LF; Matsuoka Y
    J Neurochem; 2012 Apr; 121(2):277-86. PubMed ID: 22035227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Evaluation of Clinical Candidates of γ-Secretase Inhibitors: Effects on Notch Inhibition and Promoting Beige Adipogenesis and Mitochondrial Biogenesis.
    Huang D; Qiu J; Kuang S; Deng M
    Pharm Res; 2020 Sep; 37(10):185. PubMed ID: 32888109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells.
    Rasul S; Balasubramanian R; Filipović A; Slade MJ; Yagüe E; Coombes RC
    Br J Cancer; 2009 Jun; 100(12):1879-88. PubMed ID: 19513078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
    Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
    Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted γ-secretase inhibition of Notch signaling activation in acute renal injury.
    Wyss JC; Kumar R; Mikulic J; Schneider M; Aebi JD; Juillerat-Jeanneret L; Golshayan D
    Am J Physiol Renal Physiol; 2018 May; 314(5):F736-F746. PubMed ID: 28971991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-Secretase Inhibitors and Modulators Induce Distinct Conformational Changes in the Active Sites of γ-Secretase and Signal Peptide Peptidase.
    Gertsik N; Chau DM; Li YM
    ACS Chem Biol; 2015 Aug; 10(8):1925-31. PubMed ID: 26030233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.